You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Metastatic Solid Cancers

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Malignant Tumor, ALK Fusion Protein Expression, ALK Gene Amplification Trial in Columbus (Brigatinib, Laboratory

Withdrawn
  • Advanced Malignant Neoplasm
  • +10 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Feb 15, 2022

Advanced Cholangiocarcinoma, Advanced Hepatocellular Carcinoma, Advanced Malignant Solid Tumor Trial in Los Angeles (Biospecimen

Recruiting
  • Advanced Cholangiocarcinoma
  • +6 more
  • Biospecimen Collection
  • +3 more
  • Los Angeles, California
  • +1 more
Mar 31, 2023

Metastatic Cancer, HER2 Gene Mutation Trial in Seoul (Neratinib Maleate)

Active, not recruiting
  • Metastatic Cancer
  • HER2 Gene Mutation
  • Neratinib Maleate
  • Seoul, Korea, Republic of
    Korea university Guro hospital
Oct 18, 2023

Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Recurrent Malignant Solid Tumor Trial in Houston (Laboratory

Completed
  • Advanced Malignant Solid Neoplasm
  • +3 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 21, 2022

Breast Cancer, Lung Cancer, Colorectal Cancer Trial in Kobe (e-PRO monitoring)

Enrolling by invitation
  • Breast Cancer
  • +7 more
  • e-PRO monitoring
  • Kobe, Hyogo, Japan
    Kobe University Graduate School
Jun 27, 2023

Advanced Solid Tumor, Metastatic Solid Tumor, NSCLCs Trial (PRT3789)

Recruiting
  • Advanced Solid Tumor
  • +3 more
  • Fairfax, Virginia
    NEXT Virginia
Feb 1, 2023

AXIN1 Gene Mutation, APC Gene Mutation, Solid Tumor Trial (REC-4881)

Not yet recruiting
  • AXIN1 Gene Mutation
  • +2 more
  • (no location specified)
Aug 21, 2023

Locally Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in Houston

Terminated
Has Results
  • Locally Advanced Malignant Solid Neoplasm
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 22, 2022

Metastatic Solid Tumor, BRCA1 Mutation, BRCA2 Mutation Trial in San Francisco (Niraparib, Irinotecan)

Not yet recruiting
  • Metastatic Solid Tumor
  • +4 more
  • San Francisco, California
    University of California, San Francisco
Jan 12, 2023

Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor Trial (Biopsy, Biospecimen Collection, Computed Tomography)

Not yet recruiting
  • Advanced Malignant Solid Neoplasm
  • Metastatic Malignant Solid Neoplasm
  • Biopsy
  • +3 more
  • (no location specified)
Jan 18, 2023

Metastatic Castration Resistant Prostate Cancer, Metastatic Cancer, Solid Tumor Trial in United States (Nivolumab, Ipilimumab)

Active, not recruiting
  • Metastatic Castration Resistant Prostate Cancer
  • +2 more
  • San Diego, California
  • +7 more
Jan 23, 2023

Malignant Solid Tumor, Metastatic EphA2 Positive Cancer Trial in Heidelberg (DS-8895a 1 mg/kg, DS-8895a 3 mg/kg, DS-8895a 10

Completed
Has Results
  • Malignant Solid Tumor
  • Metastatic EphA2 Positive Cancer
  • DS-8895a 1 mg/kg
  • +2 more
  • Heidelberg, Victoria, Australia
    Austin Health
Oct 3, 2022

Solid Tumor Trial in Chuo-ku (ONO-7913)

Active, not recruiting
  • Solid Tumor
  • ONO-7913
  • Chuo-ku, Tokyo, Japan
    Local Institution
May 5, 2021

NSCLC, Non-small Cell Carcinoma, Histiocytic Tumor Trial (BDTX-4933)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • +32 more
  • (no location specified)
Mar 30, 2023

Advanced Solid Tumor, Metastatic Solid Tumor Trial (89Zr?DFO?REGN5054, cemiplimab)

Not yet recruiting
  • Advanced Solid Tumor
  • Metastatic Solid Tumor
  • (no location specified)
Aug 5, 2022

Breast Cancer, Glioblastoma, Head and Neck Squamous Cell Carcinoma Trial (PRT3645)

Not yet recruiting
  • Breast Cancer
  • +5 more
  • (no location specified)
Sep 9, 2022

MSIhi or dMMR Advanced Unresectable or Metastatic Solid Tumors, Including Colorectal Cancers Trial in Kashiwa (HRO761,

Recruiting
  • MSIhi or dMMR Advanced Unresectable or Metastatic Solid Tumors, Including Colorectal Cancers
  • Kashiwa, Chiba, Japan
    Novartis Investigative Site
May 2, 2023

Advanced Solid Tumor Trial in Spain, United Kingdom, United States (AFM24, Atezolizumab 840 MG in 14 ML Injection)

Recruiting
  • Advanced Solid Tumor
  • AFM24
  • Atezolizumab 840 MG in 14 ML Injection
  • Los Angeles, California
  • +5 more
Dec 5, 2022

Adenocarcinoma of the Pancreas, Stage III Pancreatic Cancer, Stage IV Pancreatic Cancer Trial in Buffalo (dovitinib lactate,

Completed
  • Adenocarcinoma of the Pancreas
  • +3 more
  • dovitinib lactate
  • +5 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Jul 20, 2022

Hematopoietic and Lymphoid System Tumor, Metastatic Colorectal Carcinoma, Metastatic Malignant Solid Tumor Trial (BET

Not yet recruiting
  • Hematopoietic and Lymphoid System Neoplasm
  • +5 more
  • BET Bromodomain Inhibitor ZEN-3694
  • +6 more
  • (no location specified)
Apr 6, 2023

DDR Gene Mutation, Metastatic Solid Tumor Trial in Seoul (Nivolumab)

Unknown status
  • DDR Gene Mutation
  • Metastatic Solid Tumor
  • Seoul, Chongro-ku, Korea, Republic of
  • +1 more
Feb 16, 2021

Solid Tumors, Hematologic Cancers, Metastatic Cancers Trial in Paris (Vemurafenib)

Active, not recruiting
  • Solid Tumors
  • +2 more
  • Paris, France
    Tredaniel
May 18, 2022

Solid Tumor Trial in Buffalo (entolimod, pharmacological study, laboratory biomarker analysis)

Completed
  • Unspecified Adult Solid Tumor, Protocol Specific
  • Buffalo, New York
    Roswell Park Cancer Institute
Jul 20, 2022

Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in New Haven (procedure, drug, biological)

Recruiting
  • Metastatic Malignant Solid Neoplasm
  • Unresectable Malignant Solid Neoplasm
  • Biopsy
  • +2 more
  • Boston, Massachusetts
  • +2 more
Jan 25, 2023

Advanced Refractory Solid Tumors, Advanced Triple Negative Breast Cancers, Metastatic Triple Negative Breast Cancers Trial in

Recruiting
  • Advanced Refractory Solid Tumors
  • +2 more
  • Singapore, Singapore
    National University Hospital
Aug 31, 2021